DrugDashboards

Clindamycin phosphate

Clindamycin phosphate topical · CLINDAMYCIN PHOSPHATE 10 mg/mL · Solution · Topical · i3 Pharmaceuticals, LLC

NDC 72319-0696-60 · 60 APPLICATOR in 1 JAR / 1 mL in 1 APPLICATOR · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 9% over the past year, to $0.2840 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2840per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal contracts pay (FSS)$0.3333per unitA2A Alliance Pharmaceuticals, LLC · Dec 3, 2025117% of what pharmacies pay — higher than 57% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Sep 2025Sep 2026$0.284
13 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$26.05
Reported to Texas DSHS · 2026 annual filing · I3 Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$180,458
6,619 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clindamycin phosphate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA065513
TE code
AT
Approval date
Jun 17, 2010
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clindamycin phosphate topical (Solution)

LabelerStrengthFirst seenLast seen
Carnegie Pharmaceuticals, LLCCLINDAMYCIN PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
i3 Pharmaceuticals, LLCCLINDAMYCIN PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clindamycin phosphate — NDC 72319-0696-60," retrieved September 3, 2026, https://drugdashboards.com/drug/72319069660.

Free to cite with attribution — see how the data is put together.